AssetMark Inc’s Iovance Biotherapeutics IOVA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$642	Hold	183	–	–	﹤0.01%	3132
2025 Q4	$500	Sell	183 -11,026	-98%	-$25.5K	﹤0.01%	3102
2025 Q3	$24.3K	Sell	11,209 -2,705	-19%	-$6.39K	﹤0.01%	1862
2025 Q2	$23.9K	Sell	13,914 -542	-4%	-$1.35K	﹤0.01%	1764
2025 Q1	$48.1K	Buy	14,456 +2,397	+20%	+$12.4K	﹤0.01%	1449
2024 Q4	$89.2K	Sell	12,059 -794	-6%	-$7.36K	﹤0.01%	1277
2024 Q3	$121K	Buy	12,853 +4,167	+48%	+$39.5K	﹤0.01%	1117
2024 Q2	$69.7K	Buy	8,686 +2,736	+46%	+$29.3K	﹤0.01%	1171
2024 Q1	$88.2K	Sell	5,950 -3,580	-38%	-$41.7K	﹤0.01%	1065
2023 Q4	$77.5K	Buy	9,530 +654	+7%	+$3.42K	﹤0.01%	1076
2023 Q3	$40.4K	Buy	8,876 +2,718	+44%	+$17.7K	﹤0.01%	1140
2023 Q2	$43.4K	Buy	6,158 +1,935	+46%	+$13.8K	﹤0.01%	1114
2023 Q1	$25.8K	Buy	4,223 +3,166	+300%	+$21.8K	﹤0.01%	1157
2022 Q4	$6.75K	Buy	1,057 +233	+28%	+$1.82K	﹤0.01%	1327
2022 Q3	$8K	Buy	824 +329	+66%	+$3.79K	﹤0.01%	1247
2022 Q2	$5K	Buy	495 +231	+88%	+$3.03K	﹤0.01%	1303
2022 Q1	$4K	Buy	+264	New	+$4.08K	﹤0.01%	1316